Onesource Specialty Pharma Limited - Company Profile

It is a chemicals public limited company based in Thane, Maharashtra, India, established in 2007.

2007 Thane, Maharashtra, India Active

Last Updated: December 18, 2025

About Onesource Specialty Pharma Limited

Onesource Specialty Pharma Limited, a active public limited company, was established on 12 June 2007 in Thane, Maharashtra, India. Engaging in chemical products within the manufacturing sector, it holds CIN: L74140MH2007PLC432497. Registered under ROC Roc Mumbai. it is listed. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹11.46 Cr.

Formerly known as Inbiopro Solutions Private Limited, Stelis Biopharma Private Limited. It upholds a compliant status. In 2024, it reported revenue of ₹176.14 Cr and a net worth of ₹397.74 Cr. Employing 556 professional, Its leadership includes Bharat Dhirajlal Shah (Director), Rashmi Harshadrai Barbhaiya (Director), Neeraj Sharma (Managing Director). Past directors included Mohana Kumar Pillai, Joe Thomas Mangalam, Venkataraman Subramanian Iyer. It holds ₹2,444.51 Cr open charges and ₹1,294.82 Cr settled loans. Its latest AGM occurred on 23 August 2024, with the balance sheet filed on 31 March 2024. It is based at Unit No. 902, Cyber One, Plot No - 4 & 6, Sector 30A, Vashi, Navi Mumbai, Thane, Maharashtra, 400703.

Company Details

CIN/LLPIN
L74140MH2007PLC432497
Registration Number
432497
Incorporation Date
12 June 2007
Authorized Capital
₹15.00 Cr
Paid-Up Capital
₹11.46 Cr
ROC Code
Roc Mumbai
Listing Status
Listed
Company Status
Active

Key Metrics

Authorised Capital ₹ 15.00 Cr as on 18-12-2025
Paid Up Capital ₹ 11.46 Cr as on 18-12-2025
Company Age 18 Year, 7 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 2,444.51 Cr as on 18-12-2025
Satisfied Charges ₹ 1,294.82 Cr as on 18-12-2025
Revenue Growth **** 285.00% (FY 2024)
Profit Growth **** 51.15% (FY 2024)
Ebitda **** 60.89% (FY 2024)
Net Worth -49.44% (FY 2024)
Total Assets -34.85% (FY 2024)

Comprehensive Company Insights

Explore comprehensive insights into Onesource Specialty Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Onesource Specialty Pharma Limited?

Current Directors

Name	Designation	Appointment Date	Status
Bharat Dhirajlal Shah	Director	26 Jul 2024	Current
Rashmi Harshadrai Barbhaiya	Director	17 May 2024	Current
Neeraj Sharma	Managing Director	01 Mar 2024	Current
Claudio Dr Albrecht	Additional Director	27 Feb 2025	Current
Debarati Sen	Additional Director	27 Feb 2025	Current
Arun Kumar Pillai	Director	07 Apr 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	09 Jul 2018	Past
Pramod Abcsdd	Whole-Time Director	31 Jan 2020	Past
Pramod Abcsdd	Additional Director	08 Aug 2017	Past
Pramod Abcsdd	Director	18 Nov 2010	Past
Pramod Abcsdd	Nominee Director	18 Mar 2013	Past
Pramod Abcsdd	Additional Director	22 Aug 2024	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Onesource Specialty Pharma.

Onesource Specialty Pharma Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 285% increase. The company also saw a substantial improvement in profitability, with a 51.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 49.44%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

285.00%

*******

Revenue from Operations

*******

318.56%

*******

Total Assets

*******

-34.85%

*******

Profit or Loss

*******

51.15%

*******

Net Worth

*******

-49.44%

*******

EBITDA

*******

60.89%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Onesource Specialty Pharma?

In 2024, Onesource Specialty Pharma had a promoter holding of 30.29% and a public holding of 69.71%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹24,445,100,000.00

Satisfied Charges

₹12,948,159,503.00

Charges Breakdown by Lending Institutions

Others : 1848.51 Cr
Idbi Trusteeship Services Limited : 200.00 Cr
Hdfc Bank Limited : 146.00 Cr
Standard Chartered Bank : 125.00 Cr
Yes Bank Limited : 125.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
13 Nov 2025	Others	₹747.49 Cr	Open
25 Sep 2025	Others	₹150.00 Cr	Open
22 Sep 2025	Others	₹100.00 Cr	Open
29 Aug 2025	Standard Chartered Bank	₹125.00 Cr	Open
19 Jun 2025	Yes Bank Limited	₹50.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Onesource Specialty Pharma?

Onesource Specialty Pharma has a workforce of 556 employees as of Mar 10, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Onesource Specialty Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Onesource Specialty Pharma's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Onesource Specialty Pharma

Recent Activity within the Organization

Charges

A charge registered on 25 Mar 2025 via Charge ID 101080271 with Others was fully satisfied on 06 Dec 2025. was recorded as a recent event.
06 Dec 2025
Charges

A charge with Others amounted to Rs. 747.49 Cr with Charge ID 101193627 was registered on 13 Nov 2025. was recorded as a recent event.
13 Nov 2025
Charges

A charge with Others of Rs. 190.00 Cr registered on 13 Mar 2025 with Charge ID 101076043 was modified on 04 Nov 2025. was recorded as a recent event.
04 Nov 2025
Charges

A charge with Others amounted to Rs. 150.00 Cr with Charge ID 101167111 was registered on 25 Sep 2025. was recorded as a recent event.
25 Sep 2025
Charges

A charge with Hdfc Bank Limited of Rs. 146.00 Cr registered on 28 Feb 2025 with Charge ID 101080678 was modified on 23 Sep 2025. was recorded as a recent event.
23 Sep 2025
Charges

The activity A charge with Others amounted to Rs. 100.00 Cr with Charge ID 101167815 was registered on 22 Sep 2025. was completed.
22 Sep 2025

Explore recent activity and updates - View Recent Activity